Melphalan Injection and Tolmetin: Interaction Details
- Melphalan Injection
- EvomelaAlkeranHepzato +1 more
- Tolmetin
- TolectinTolectin DSTolectin 600
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Melphalan Injection and Tolmetin interaction:
Melphalan Injection
- Evomela
- Alkeran
- Hepzato
- Ivra
Tolmetin
- Tolectin
- Tolectin DS
- Tolectin 600
What Happens When You Take Melphalan Injection With Tolmetin
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Using melphalan together with can raise the likelihood of bleeding. Medications that affect function, NSAIDs among them, should be stopped one week prior to the melphalan procedure.1
The Melphalan Injection and Tolmetin Interaction, Explained
Melphalan is a chemotherapy medicine that can lower your counts, the blood cells that help you form clots. Tolmetin is an (a pain and arthritis medicine) that also makes platelets work less well. Taken together, they may add up and raise your chance of bleeding or bruising more easily.
This concern is mostly based on how the drugs work rather than on large studies, but the label still takes it seriously. Please don't stop or change anything on your own. Your care team can plan the timing of tolmetin around your melphalan treatment and keep a close eye on you.
Mechanism: effect on hemostasis. Melphalan causes dose-related , including . Tolmetin, a nonselective COX , reversibly impairs aggregation and can irritate the mucosa. No PK interaction is implied.
- Direction: increased bleeding risk (GI and other sites).
- Evidence: theoretical; onset unspecified; severity listed as major.
- Management: per labeling, discontinue drugs affecting platelet function, such as , one week before the melphalan procedure. Monitor platelet counts and for signs of bleeding. Individualize with the care team, and consider a non-NSAID analgesic alternative.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Melphalan Injection and Tolmetin Interact
The likely mechanism
effects on hemostasis
How to Manage the Melphalan Injection and Tolmetin Interaction
Your care team typically plans ahead for this combination. The documented guidance is that like tolmetin that affect function are discontinued one week before a melphalan procedure.
- Tell your oncology team and pharmacist that you take tolmetin, including how often.
- Ask them exactly when, and whether, to stop it before treatment. Don't stop or restart it on your own.
- Ask what you can use for pain or inflammation instead.
- Your team may monitor you more closely, and you should report unusual bruising, nosebleeds, black or bloody stools, or other bleeding right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Melphalan Injection or Tolmetin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Melphalan Injection and Tolmetin: Common Questions
How serious is the Melphalan Injection and Tolmetin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Melphalan Injection and Tolmetin interaction managed?
Your care team typically plans ahead for this combination. The documented guidance is that like tolmetin that affect function are discontinued one week before a melphalan procedure. Tell your oncology team and pharmacist that you take tolmetin, including how often. Ask them exactly when, and whether, to stop it before treatment. Don't stop or restart it on your own. Ask what you ca… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Melphalan Injection and Tolmetin Interaction
Ask in your own words about taking Melphalan Injection and Tolmetin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: HEPZATO intraartieral injection, melphalan intraarterial injection. Delcath Systems Inc (per FDA), Queensbury, NY, 2023.
Other Serious Interactions of Melphalan Injection and Tolmetin
Also serious with Melphalan Injection
Also serious with Tolmetin
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.